Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Nitropyridine >  3-Bromo-4-methyl-5-nitropyridine

3-Bromo-4-methyl-5-nitropyridine

Basic information Safety Supplier Related

3-Bromo-4-methyl-5-nitropyridine Basic information

Product Name:
3-Bromo-4-methyl-5-nitropyridine
Synonyms:
  • 3-Bromo-4-methyl-5-nitropyridine
  • 3-Bromo-4-methy-5nitro-pyridine
  • Pyridine, 3-bromo-4-methyl-5-nitro-
  • 3-Bromo-4-methyl-5-nitropyridine ISO 9001:2015 REACH
  • 4-Methyl-5-Bromo-3-Nitropyridine
CAS:
69872-15-7
MF:
C6H5BrN2O2
MW:
217.02
Product Categories:
  • Heterocycle-Pyridine series
Mol File:
69872-15-7.mol
More
Less

3-Bromo-4-methyl-5-nitropyridine Chemical Properties

Melting point:
57-58℃
Boiling point:
269℃
Density 
1.709
Flash point:
116℃
storage temp. 
Sealed in dry,Room Temperature
pka
-0.51±0.28(Predicted)
Appearance
Off-white to light yellow Solid
InChI
InChI=1S/C6H5BrN2O2/c1-4-5(7)2-8-3-6(4)9(10)11/h2-3H,1H3
InChIKey
WFCIQRPATFRBOY-UHFFFAOYSA-N
SMILES
C1=NC=C([N+]([O-])=O)C(C)=C1Br
More
Less

3-Bromo-4-methyl-5-nitropyridine Usage And Synthesis

Uses

3-Bromo-4-methyl-5-nitropyridine is an intermediate used in the synthesis of 4-bromo-6-azaindole and other azaindole derivatives.

Synthesis

31872-63-6

105-53-3

69872-15-7

GENERAL STEPS: Diethyl malonate (3.84 mL, 25.3 mmol) was slowly added dropwise to a suspension of sodium hydride (1.01 g, 60% oil suspension, 25.3 mmol) in DMF (15 mL) at 0 °C and stirred for 30 min until gas escape ceased. Subsequently, 3-bromo-4-chloro-5-nitropyridine (3.00 g, 12.6 mmol) was slowly added and the resulting dark reddish brown solution was stirred for 1 hour at room temperature. Upon completion of the reaction, it was carefully quenched with water and the pH was adjusted to 1 with 1 N HCl. The aqueous phase was extracted with EtOAc (2 x 150 mL), the organic phases were combined and washed with deionized water (100 mL) and saturated saline, dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue was dissolved in 4N HCl (50 mL) and refluxed for 16 hours. The reaction mixture was cooled in an ice bath and neutralized with 50% NaOH solution to pH 7. The aqueous phase was again extracted with EtOAc (3 x 100 mL), the organic phases were combined and washed with saturated saline, dried over MgSO4, filtered and concentrated under reduced pressure to afford the target product 3-bromo-4-methyl-5-nitropyridine (94a, 1.90 g, 70% yield) as a yellow solid. The product was characterized by 1H NMR (300 MHz, CDCl3): δ 8.94 (s, 1H), 8.97 (s, 1H), 2.65 (s, 3H).

References

[1] Journal of Medicinal Chemistry, 2014, vol. 57, # 6, p. 2462 - 2471
[2] Patent: US2005/90529, 2005, A1. Location in patent: Page/Page column 82

3-Bromo-4-methyl-5-nitropyridineSupplier

Shanghai Helai Biotech Co. Ltd. Gold
Tel
15721400568
Email
helaibiotech@163.com
Shaanxi Dideu Newmaterial Co., Ltd. Gold
Tel
029-63373950 17392213970
Email
1052@dideu.com
Shijiazhuang suchen Chemical Technology Co. LTD Gold
Tel
186-33933494 18032288352
Email
1130239@qq.com
Suzhou Xinrui Biotechnology Co., Ltd. Gold
Tel
13401437572
Email
xinruibiotech01@163.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com